Norge -
norsk -
Statens legemiddelverk
nitisinone dipharma 5 mg
dipharma arzneimittel gmbh - nitisinon - kapsel, hard - 5 mg
Norge -
norsk -
Statens legemiddelverk
nitisinone dipharma 10 mg
dipharma arzneimittel gmbh - nitisinon - kapsel, hard - 10 mg
Norge -
norsk -
Statens legemiddelverk
nitisinone dipharma 2 mg
dipharma arzneimittel gmbh - nitisinon - kapsel, hard - 2 mg
Norge -
norsk -
Statens legemiddelverk
nitisinone dipharma 20 mg
dipharma arzneimittel gmbh - nitisinon - kapsel, hard - 20 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
nitisinone mdk (previously nitisinone mendelikabs)
mendelikabs europe ltd - nitisinone - tyrosinemias - andre alimentary tract and metabolism products, - behandling av pasienter med voksne og pediatriske pasienter (i alle aldersgrupper) med bekreftet diagnose av arvelig tyrosinemi type 1 (ht 1) i kombinasjon med diettbegrensning av tyrosin og fenylalanin.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
orfadin
swedish orphan biovitrum international ab - nitisinone - tyrosinemias - andre alimentary tract and metabolism products, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).
Den europeiske union -
norsk -
EMA (European Medicines Agency)
nityr
cycle pharmaceuticals (europe) ltd - nitisinone - tyrosinemias - andre alimentary tract and metabolism products, - behandling av voksne og paediatric pasienter med bekreftet diagnosen arvelig tyrosinemia type 1 (ht-1) i kombinasjon med kosttilskudd begrensning av tyrosin og fenylalanin.
Norge -
norsk -
Statens legemiddelverk
minoksidil norfri 50 mg/ ml
evolan pharma ab - minoksidil - liniment, oppløsning - 50 mg/ ml
Den europeiske union -
norsk -
EMA (European Medicines Agency)
tachosil
corza medical gmbh - human fibrinogen, human trombin - hemostase, kirurgisk - antihemoragika - tachosil is indicated in adults and children from 1 month of age for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for suture support in vascular surgery where standard techniques are insufficient. tachosil is indicated in adults for supportive sealing of the dura mater to prevent postoperative cerebrospinal leakage following neurological surgery (see section 5.